Genmab — August 2015
-
nej dejligt Novartis vil betale 1 mia. $ for indiaktionerne. Tyder da på det ser et seriøst potentiale her. Nu skal der bare fut over stepperne på udviklingen. Men forhåbentlig har GSK lavet protokoller etc. klar som de kan anvende?
-
Fik lige lidt flere GEN ind på bogen. Syntes det er synd at lade chancen gå til spilde. PS..Det tænkte jeg også i 209 i går.

-
Sorry 609...Solgte i 597.

-
Lidt mere held i sprøjten i dag.

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind